Inventor
WALLACE ELI M
US72 patents
⚠️ This page may combine multiple inventors who share the name “WALLACE ELI M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARRAY BIOPHARMA INC
23 patentsUS7732616B2Jun 8, 2010
Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC35 citations96
US7449486B2Nov 11, 2008
Mitotic kinesin inhibitors and methods of use thereof
ARRAY BIOPHARMA INC37 citations96
US7425637B2Sep 16, 2008
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC27 citations96
US7235537B2Jun 26, 2007
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC53 citations96
US7271178B2Sep 18, 2007
Heterocyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC18 citations93
US8003651B2Aug 23, 2011
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
ARRAY BIOPHARMA INC35 citations92
US7777050B2Aug 17, 2010
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC13 citations92
US9969727B2May 15, 2018
Pyrrolopyridines as kinase inhibitors
ARRAY BIOPHARMA INC6 citations84
US9365568B2Jun 14, 2016
Pyrrolopyridines as kinase inhibitors
ARRAY BIOPHARMA INC4 citations84
US8981085B2Mar 17, 2015
Pyrrolopyridines as kinase inhibitors
ARRAY BIOPHARMA INC10 citations84
US8758830B2Jun 24, 2014
Pyrrolopyridines as kinase inhibitors
ARRAY BIOPHARMA INC6 citations84
US8372842B2Feb 12, 2013
Pyrazolopyridines as kinase inhibitors
ARRAY BIOPHARMA INC15 citations84
US7956073B2Jun 7, 2011
Mitotic kinesin inhibitors and methods of use thereof
ARRAY BIOPHARMA INC8 citations84
US7893065B2Feb 22, 2011
Heterocyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC14 citations84
US7538120B2May 26, 2009
Method of treating inflammatory diseases
ARRAY BIOPHARMA INC11 citations84
US7511058B2Mar 31, 2009
Heterocyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC8 citations84
US9359340B2Jun 7, 2016
Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors
ARRAY BIOPHARMA INC9 citations83
US9221841B2Dec 29, 2015
Mitotic kinesin inhibitors and methods of use thereof
ARRAY BIOPHARMA INC5 citations83
US7795282B2Sep 14, 2010
Mitotic kinesin inhibitors and methods of use thereof
ARRAY BIOPHARMA INC9 citations83
US8003805B2Aug 23, 2011
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC5 citations74
US7973170B2Jul 5, 2011
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC5 citations74
US7576114B2Aug 18, 2009
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC5 citations74
US6586467B2Jul 1, 2003
Preparation of phosphatase inhibitors
ARRAY BIOPHARMA INC11 citations73
PELOTON THERAPEUTICS INC
8 patentsUS9908845B2Mar 6, 2018
Aryl ethers and uses thereof
PELOTON THERAPEUTICS INC16 citations92
US10597366B2Mar 24, 2020
Aryl ethers and uses thereof
PELOTON THERAPEUTICS INC4 citations83
US10144711B2Dec 4, 2018
Aryl ethers and uses thereof
PELOTON THERAPEUTICS INC8 citations83
US9969689B2May 15, 2018
Aryl ethers and uses thereof
PELOTON THERAPEUTICS INC8 citations83
US9896418B2Feb 20, 2018
Aryl ethers and uses thereof
PELOTON THERAPEUTICS INC9 citations83
US9884843B2Feb 6, 2018
Cyclic sulfone and sulfoximine analogs and uses thereof
PELOTON THERAPEUTICS INC9 citations83
US10278942B2May 7, 2019
Compositions for use in treating pulmonary arterial hypertension
PELOTON THERAPEUTICS INC7 citations76
USRE49948EApr 30, 2024
Aryl ethers and uses thereof
PELOTON THERAPEUTICS INC1 citations72
HANS JEREMY
4 patentsUS8623895B2Jan 7, 2014
Mitotic kinesin inhibitors and methods of use thereof
HANS JEREMY4 citations83
US8236825B2Aug 7, 2012
Mitotic kinesin inhibitors and methods of use thereof
HANS JEREMY7 citations83
US8268871B2Sep 18, 2012
Mitotic kinesin inhibitors and methods of use thereof
HANS JEREMY7 citations82
US8580828B2Nov 12, 2013
Mitotic kinesin inhibitors and methods of use thereof
HANS JEREMY5 citations81
WALLACE ELI M
4 patentsUS8513293B2Aug 20, 2013
Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal
WALLACE ELI M5 citations83
US8193230B2Jun 5, 2012
Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
WALLACE ELI M2 citations73
US8193231B2Jun 5, 2012
Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
WALLACE ELI M2 citations73
US8178693B2May 15, 2012
N3 alkylated benzimidazole derivatives as MEK inhibitors
WALLACE ELI M4 citations73
MITCHELL IAN S
3 patentsUS8063050B2Nov 22, 2011
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MITCHELL IAN S63 citations97
US8853199B2Oct 7, 2014
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MITCHELL IAN S20 citations92
US8846681B2Sep 30, 2014
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MITCHELL IAN S11 citations83
BLAKE JAMES F
3 patentsUS8211921B2Jul 3, 2012
Heterocyclic inhibitors of MEK and methods of use
BLAKE JAMES F12 citations92
US8431574B2Apr 30, 2013
Heterocyclic inhibitors of MEK and methods of use thereof
BLAKE JAMES F6 citations84
US8268852B2Sep 18, 2012
Heterocyclic inhibitors of MEK and methods of use thereof
BLAKE JAMES F4 citations73
BANKA ANNA L
2 patentsLE HUEROU YVAN
2 patentsNOVARTIS AG
1 patentShowing the top 50 of 72 patents by PatentIndex Score.